Relmada Therapeutics, Inc. Common Stock

$5.77

-0.38 (-6.10%)

Volume:

1.225M ($7.24M)

#1511 Volume #2572 Dollar Volume

Market Capitalization:

$423.13M

#3046 Market Cap

Relmada Therapeutics Price Chart

Relmada Therapeutics Volume Chart

Relmada Therapeutics Market Segments

After Hours

-0.14(-2.37%)

Open	$5.91
Close	$5.77
Low	$5.76
Low Change	-0.15 (-2.54%)
High	$5.95
High Change	+0.04 (+0.68%)
Range	$0.19
Volume	1.897K
Dollar Volume	$10.95K

Regular Trading Hours

-0.23(-3.75%)

Open	$6.14
Close	$5.91
Low	$5.82
Low Change	-0.32 (-5.21%)
High	$6.45
High Change	+0.31 (+5.05%)
Range	$0.63
Volume	1.221M
Dollar Volume	$7.21M

Premarket

+0.13(+2.16%)

Open	$6.03
Close	$6.16
Low	$6.03
Low Change	0.00 (0.00%)
High	$6.16
High Change	+0.13 (+2.16%)
Range	$0.13
Volume	2.485K
Dollar Volume	$15.31K

After Hours Yesterday

+0.05(+0.81%)

Open	$6.15
Close	$6.20
Low	$6.07
Low Change	-0.08 (-1.30%)
High	$6.22
High Change	+0.07 (+1.14%)
Range	$0.15
Volume	6.338K
Dollar Volume	$39.30K

Regular Trading Hours Yesterday

-0.09(-1.36%)

Open	$6.23
Close	$6.15
Low	$5.95
Low Change	-0.28 (-4.49%)
High	$6.28
High Change	+0.05 (+0.83%)
Range	$0.33
Volume	1.301M
Dollar Volume	$8.00M

Premarket Yesterday

-0.05(-0.79%)

Open	$6.30
Close	$6.25
Low	$6.25
Low Change	-0.05 (-0.79%)
High	$6.35
High Change	+0.05 (+0.79%)
Range	$0.10
Volume	8.999K
Dollar Volume	$56.24K

Relmada Therapeutics Moving Averages

5 Day Moving Average (SMA5)	$6.14
10 Day Moving Average (SMA10)	$5.39
20 Day Moving Average (SMA20)	$4.76
50 Day Moving Average (SMA50)	$4.32
100 Day Moving Average (SMA100)	$3.96
200 Day Moving Average (SMA200)	$2.48

Relmada Therapeutics Statistics

Average Volume (30 Days)	2.17M
P/E Ratio (Current)	-8.21
EPS (Current)	-$0.77
Dividend Yield	0.00%
Free Cash Flow	—
Cash Ratio	0.27
Current Ratio	2.86
Quick Ratio	2.86
Debt to Equity	0.00
Enterprise Value	$462.08M
EV to EBITDA	-7.99
EV to Sales	—
Price to Book	48.96
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	—
Return on Assets	-3.78%
Return on Equity	-5.93%

Relmada Therapeutics Stock Splits

There have been 2 stock splits for Relmada Therapeutics (RLMD). The last reverse stock split occured on September 30, 2019 and reduced the outstanding shares at a ratio of 4:1.

Date	Type	Ratio
Sep 30, 2019	Reverse	4:1
Aug 12, 2015	Reverse	5:1

Relmada Therapeutics Dividends

There have been no dividends for Relmada Therapeutics (RLMD).